TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05848687 |
|
Recruitment Status :
Recruiting
First Posted : May 8, 2023
Last Update Posted : February 22, 2024
|
Sponsor:
Tanja Andrea Gruber
Collaborators:
Pediatric Oncology Experimental Therapeutics Investigators' Consortium
Amgen
Lucile Packard Foundation for Children's Health
Kura Oncology, Inc.
Information provided by (Responsible Party):
Tanja Andrea Gruber, Stanford University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2028 |
| Estimated Study Completion Date : | December 2033 |